Business Daily Media


Telecommunications

Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye disease-PR Newswire APAC

  • Written by PR Newswire

-- Medical Research Commercialisation Fund (MRCF) in raise for registration study to treat Meibomian gland dysfunction, the leading cause of Dry Eye Disease

-- Meibomian gland dysfunction affects more than 30 million adults in the United States alone - registration studies used to seek potential regulatory approval with the FDA

-- Financing also...

Read more: Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye...

Writers Wanted



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion